Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension
Background: In 2012, mutations in Cav1 were found to be the driving mutation in several cases of heritable pulmonary arterial hypertension (PAH). These mutations replaced the last 21 amino acids of Cav1 with a novel 22-amino-acid sequence. Because previously only Cav1 knockouts had been studied in t...
Main Authors: | Anandharajan Rathinasabapathy, Courtney Copeland, Amber Crabtree, Erica J. Carrier, Christy Moore, Sheila Shay, Santhi Gladson, Eric D. Austin, Anne K. Kenworthy, James E. Loyd, Anna R. Hemnes, James D. West |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00540/full |
Similar Items
-
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
by: Anandharajan Rathinasabapathy, et al.
Published: (2018-04-01) -
KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models
by: James D. West, et al.
Published: (2021-05-01) -
Caveolins: Targeting Pro-survival Signaling in the Heart and Brain
by: Creed M. Stary, et al.
Published: (2012-10-01) -
Caveolin‐1 associated with severe (pediatric‐onset) presentation of pulmonary arterial hypertension
by: Rachel Farrell, et al.
Published: (2022-07-01) -
Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
by: James West, et al.
Published: (2021-09-01)